- Affiliates of The Carlyle Group and GTCR LLC have agreed to acquire Albany Molecular Research (NASDAQ:AMRI) for $21.75 per share. Albany's board has unanimously endorsed the deal.
- The transaction will be financed with debt and equity.
- Shares are up 9% premarket on robust volume.
- Previously: Albany Molecular exploring sale; shares up 8% (April 7)
Carlyle Group takes out Albany Molecular Research for $21.75/share; +9% premarket
Recommended For You
More Trending News
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
AMRI | - | - |
Albany Molecular Research, Inc. |